STAT - 24 Aug 2020
When people get sick with Covid-19, their immune systems generate antibodies to fight the disease. Those antibody proteins float in their blood plasma — the ...
Johns Hopkins Bloomberg School of Public Health - 13 Jan 2025
Bloomberg School Researchers Support First Blood Center to Receive Full FDA Approval to Provide Convalescent Plasma for Patients Who Are Immunocompromised ...
The Lancet - 19 Mar 2025
COVID-19 convalescent plasma in immunocompromised COVID-19 patients: more certainty and clarity are added to a complex evidence base - eBioMedicine ...
Frontiers - 05 Sep 2024
The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness ...
The Lancet - 27 Feb 2025
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial - eBioMedicine ...
Newswise - 19 Mar 2025
Post-Transfusion Activation of Coagulation Pathways During Severe COVID-19 Correlates with COVID-19 Convalescent Plasma Antibody Profiles | Newswise ...
Frontiers - 31 Jul 2024
The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity ...
ResearchGate - 24 Feb 2025
(PDF) Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study ...
ResearchGate - 09 Dec 2024
(PDF) Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection ...
ResearchGate - 10 Dec 2024
(PDF) Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study ...